Advanced ovarian cancer drug gets initial ‘no’ for NHS in England 08-12-2019 mediabest Health Problems A targeted drug with potential to slow the progress of Read more
ASCO: Pembrolizumab superior for initial Tx of advanced NSCLC 06-04-2018 James Health Problems (HealthDay)—For patients with programmed death ligand 1 (PD-L1)-expressing locally advanced Read more